Viewing Study NCT00079729



Ignite Creation Date: 2024-05-05 @ 11:32 AM
Last Modification Date: 2024-10-26 @ 9:10 AM
Study NCT ID: NCT00079729
Status: COMPLETED
Last Update Posted: 2012-10-29
First Post: 2004-03-11

Brief Title: Directly Observed Therapy in HIV Infected Adolescent Focus Groups
Sponsor: National Institute of Allergy and Infectious Diseases NIAID
Organization: National Institute of Allergy and Infectious Diseases NIAID

Study Overview

Official Title: Directly Observed Therapy DOT in HIV-Infected Adolescents Part A-Focus Groups
Status: COMPLETED
Status Verified Date: 2012-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this study is to help researchers use information from HIV infected adolescents to design a directly observed therapy DOT program that will help adolescents take their anti-HIV medications correctly
Detailed Description: The rate of HIV infection among adolescents is increasing at an alarming rate Adherence to antiretroviral therapy has been a major challenge in achieving and maintaining adequate control of the disease in this population DOT has been shown effective in individuals with tuberculosis TB but DOT in HIV infected populations has not been thoroughly examined This study will collect information from HIV infected adolescents in order to establish a DOT program that will increase successful adherence to HIV treatment and will benefit the public by preventing development of viral resistance and reducing the risk of transmission

Adolescent participants in this study will be assigned to one of three 2-hour focus group sessions each at a different site The participants will complete a questionnaire and will give input about designing a DOT intervention model that will be accepted by adolescents The model will then be used in a pilot study to determine the feasibility of implementing DOT programs in the community to help HIV infected adolescents

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
10193 REGISTRY DAIDS ES Registry Number None